SASP components induced by MEK and CDK4/6 combination inhibition synergistically inhibit tumor progression through natural killer cell-mediated cytotoxicity in C57BL/6 immunocompetent mice injected with KrasG12D/+; Trp53–/–(KP) lung tumors [26]. This evidence concerns the gene MAP2K7 and neoplasm.